Abstract |
2-[(2-Methoxy-4-methylsulfinyl)phenyl]-1H-imidazo[4,5- b]pyridine ( AR-L 115 BS) was investigated in 14 patients with coronary artery disease (CAD) and an elevated left ventricular enddiastolic pressure at rest (LVEDP). There was a significant decrease in the systolic (AOPS) and diastolic aortic pressures (AOPD) of 9% and 6%, respectively, (p less than 0.001, p less than 0.01). The LVEDP decreased by 29% (p less than 0.001), and the maximum rate of pressure rise (dp/dt max) increased by 19% (p less 0.001). The systolic (PAPS) and diastolic pulmonary artery pressures (PAPD) fell by 17% and 16%, respectively (p less than 0.05). The cardiac index (CI) increased by 12% (p less than 0.05), and the peripheral resistance (SVR) fell by 17% (p less than 0.001). Heart rate increased slightly by 5% (p less than 0.1) but this was of no clinical relevance. The right atrial pressure (RAP) and the tension time index (TTI) remained unchanged. AR-L 15 BS was observed to have vasodilating and positive inotropic effects without increasing oxygen consumption. It can therefore be recommended for use in patients with CAD and an elevated LVEDP. Side-effects have not been reported.
|
Authors | A Weikl, S Kohlschütter, O E Durst, E Lang |
Journal | Arzneimittel-Forschung
(Arzneimittelforschung)
Vol. 31
Issue 1a
Pg. 244-7
( 1981)
ISSN: 0004-4172 [Print] Germany |
PMID | 7195232
(Publication Type: Journal Article)
|
Chemical References |
- Cardiotonic Agents
- Imidazoles
- sulmazole
|
Topics |
- Adult
- Blood Pressure
(drug effects)
- Cardiac Catheterization
- Cardiac Output
(drug effects)
- Cardiotonic Agents
(pharmacology)
- Coronary Disease
(physiopathology)
- Electrocardiography
- Female
- Hemodynamics
(drug effects)
- Humans
- Imidazoles
(pharmacology)
- Male
- Middle Aged
- Time Factors
|